Advanced Search
Now showing items 1-10 of 24
Neurotoxins as Preclinical Models for Parkinson’s Disease
(Springer New York LLC, 2018)
Aminochrome as preclinical model for Parkinson's disease
(Impact Journals LLC, 2017)
Aminochrome induces microglia and astrocyte activation
(Elsevier, 2017)
Aminochrome as new preclinical model to find new pharmacological treatment that stop the development of parkinsons disease
(Bentham Science Publishers B.V., 2016)